Peginterferon alfa-2b: all 135 studies that test it
Page 1 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical ResectionNot yet recruitingNCT07553767Early Phase 1
- Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis BNot yet recruitingNCT07231276Phase 4
- Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease .RecruitingNCT07008755Not applicable
- Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus PneumoniaRecruitingNCT06881056Not applicable
- Peginterferon α-2b Injection for the Treatment of Pediatric RSV BronchiolitisRecruitingNCT06827249Not applicable
- Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in AdultsEnrolling by invitationNCT06777173Not applicable
- Efficacy and Safety of Peginterferon in ET and PV.RecruitingNCT06734637Not applicable
- Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ETRecruitingNCT06552429Phase 2
- Peginterferon α-2b Combined CO2 Laser in Condylomata AcuminataNot yet recruitingNCT06430190Not applicable
- Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential ThrombocythemiaRecruitingNCT05395507Phase 2
- Peginterferon Treatment Study for Inactive Chronic Hepatitis B PatientsRecruitingNCT05182463Phase 4
- Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential ThrombocythemiaRecruitingNCT04226950Phase 2
- Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)CompletedNCT03554005Phase 1Results posted
- SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)TerminatedNCT03552549Phase 2/3Results posted
- Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)TerminatedNCT03547154Phase 2/3Results posted
- Efficacy of Polyethylene Glycol-Interferon Alfa-2B (PEG-Intron, SCH 54031) Compared to Interferon Alfa-2B in Participants With Chronic Hepatitis C (MK-4031-016)CompletedNCT03537274Phase 2/3Results posted
- Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-IntronTerminatedNCT02982720Phase 2Results posted
- Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerTerminatedNCT02948426Phase 1Results posted
- Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway GliomasCompletedNCT02343224Phase 2Results posted
- Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell CarcinomaCompletedNCT02218164Phase 2Results posted
- A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)CompletedNCT02155322Phase 2Results posted
- Peginterferon Alfa-2b in Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By SurgeryTerminatedNCT01964300Phase 2Results posted
- Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107)CompletedNCT01945294Phase 3Results posted
- Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIVCompletedNCT01935089Phase 2Results posted
- A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038)CompletedNCT01710501Phase 2Results posted
- An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C VirusTerminatedNCT01701063Phase 1/2Results posted
- Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)CompletedNCT01678131Phase 1Results posted
- A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450)TerminatedNCT01641926Phase 3Results posted
- A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370)TerminatedNCT01636960Phase 1Results posted
- Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)TerminatedNCT01606800Phase 4Results posted
- Yervoy With Sylatron Unresectable Stage 3 or 4 MelanomaCompletedNCT01496807Phase 1Results posted
- Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV InfectionCompletedNCT01482767Phase 3Results posted
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected PatientsCompletedNCT01468584Phase 3Results posted
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Relapser Genotype 2 Hepatitis C Infected PatientsCompletedNCT01466192Phase 3Results posted
- Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIVTerminatedNCT01443923Phase 4Results posted
- Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)CompletedNCT01432535Phase 1Results posted
- A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) InfectionCompletedNCT01366638Phase 3Results posted
- Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral TherapyCompletedNCT01295515Phase 1/2Results posted
- Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/LymphomaTerminatedNCT00854581Phase 4Results posted
- Medical Treatment of "High-Risk" NeurofibromasCompletedNCT00846430Phase 2Results posted
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based TherapyCompletedNCT00781274Phase 3Results posted
- Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based TherapyCompletedNCT00780910Phase 3Results posted
- 5 Year Long-term Follow up in Pediatric Participants Who Received PegIntron Plus Rebetol in P02538 Part I (P02538 Pt 2)CompletedNCT00761735Phase 3Results posted
- Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)CompletedNCT00759109Phase 3Results posted
- Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCLTerminatedNCT00724061Not applicableResults posted
- Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)TerminatedNCT00687544Phase 4Results posted
- Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116)CompletedNCT00687219Phase 3Results posted
- Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)TerminatedNCT00686881Phase 3Results posted
- Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)CompletedNCT00686790Phase 3Results posted
- Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)CompletedNCT00686777Phase 4Results posted
- A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis CCompletedNCT00630058Phase 1Results posted
- PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00589550Phase 1Results posted
- Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaTerminatedNCT00588146Phase 2Results posted
- Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid LeukemiaTerminatedNCT00573378Phase 2Results posted
- PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)CompletedNCT00536263Phase 3Results posted
- An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C ParticipantsCompletedNCT00528528Phase 2Results posted
- Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma PatientsCompletedNCT00525031Phase 2Results posted
- Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerTerminatedNCT00467077Phase 2Results posted
- High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)CompletedNCT00457418Phase 1Results posted
- The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)TerminatedNCT00441584Phase 3Results posted
- Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)TerminatedNCT00415857Phase 2Results posted
- Study of PEG-Intron for Plexiform NeurofibromasCompletedNCT00396019Phase 2Results posted
- PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)CompletedNCT00371761Phase 3Results posted
- Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)CompletedNCT00302081Phase 3Results posted
- Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)TerminatedNCT00255034Phase 4Results posted
- Study of Long-term Peg Intron vs. Colchicine in Non-responders.CompletedNCT00179413Phase 4Results posted
- Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With OsteosarcomaCompletedNCT00134030Phase 3Results posted
- Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)CompletedNCT00104052Phase 3Results posted
- PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerTerminatedNCT00090870Phase 2Results posted
- Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)CompletedNCT00049842Phase 3Results posted
- PEG-Interferon Alfa-2b in Treating Patients With Stage IV MelanomaCompletedNCT00049530Phase 2Results posted
- Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569)CompletedNCT00048724Phase 3Results posted
- A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis BCompletedNCT04846491Phase 3
- Rituximab and Pegylated Interferon α-2b in Patients With Indolent B-cell LymphomaStatus unknownNCT04246359Phase 2
- Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)Status unknownNCT03588715Phase 1
- Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCTCompletedNCT02634294Phase 2/3
- New Strategy Study of Functional Cure of Chronic Hepatitis BStatus unknownNCT02605252Not applicable
- A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)Status unknownNCT02327416Phase 3
- Reducing Proviral HIV DNA With Interferon-aStatus unknownNCT02227277Phase 2
- Treatment of Advanced Melanoma With MK-3475 and PeginterferonCompletedNCT02112032Phase 1
- Efficacy and Safety of the Combination Vitamin D With Standard of Care in Egyptian Patients With Untreated Chronic Hepatitis CWithdrawnNCT02099604Phase 3
- Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid LeukaemiaCompletedNCT02001818Phase 2
- Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral TherapyCompletedNCT01928511Phase 4
- Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic PhaseCompletedNCT01872442Phase 2
- Nilotinib Plus Pegylated Interferon-α2b in CMLTerminatedNCT01866553Phase 2
- HCV Treatment in HIV Co-Infected Patients in AsiaCompletedNCT01838772Phase 4
- A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)WithdrawnNCT01727271Phase 4
- Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)WithdrawnNCT01641666Phase 3
- Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)WithdrawnNCT01590225Phase 3
- Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)WithdrawnNCT01547312Phase 1
- Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHBCompletedNCT01532843Phase 4
- Adjuvant PEG Intron in Ulcerated MelanomaStatus unknownNCT01502696Phase 3
- A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid NeoplasmsCompletedNCT01387763Phase 3
- Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/RibavirinCompletedNCT01335529Phase 2
- Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)Status unknownNCT01325896Phase 2
- Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis BStatus unknownNCT01243281Not applicable
- Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)CompletedNCT01121705Phase 3
- Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)CompletedNCT01081158Phase 1
- PEG-IFN Plus Ribavirin Combination Therapy for Older PatientsStatus unknownNCT00956982Not applicable
- 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular CorrelatesTerminatedNCT00886457Phase 1